For example, in anti-PD-1 refractory lung tumors, upregulation of TIM-3 on T cells drives immune escape, and adding a TIM-3-blocking antibody can restore anti-tumor immunity (Koyama et al., 2016). Here, HAVCR2 is linked to neoplasm.